Advancement in Ischemic Stroke

Image

On behalf of the Journal of Experimental Stroke & Translational Medicine, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, it’s been 11 long years we have started the Journal, now we are celebrating the 11th Anniversary and we are privileged to welcome Experimental Stroke Society.

Stroke is the second most basic reason for demise on the planet particularly in the ageing population. Where Neuroinflammation is one of the hotly debated issues in the investigation of mechanism of ischaemic stroke, Advances in the refined diagnosis and treatment of stroke are driving quickened change with precision medicine.

Realizing the importance of this field, Open Access Journals have organizing a prestigious conference 10th International Conference on Neurological disorders & Stroke August 21-22, 2020 Paris, France by Experimental Stroke & Translational Medicine.

Open Access Journals through its novel initiative is committed to bring forth genuine and reliable scientific contributions to the relevant community. This platform with a sole aim of providing the most trusted scientifically authentic information is launched to support the latest logical scientific initiatives. The motto of the Open Access Journals is to promote flawless, unbiased research information and data, by maintaining at most transparency and following the already laid international publishing standard.

 

With regards,

Joseph Marreddy
Journal of Experimental Stroke & Translational Medicine
WhatsApp: +3225889658
Email id: strokemed@emedscience.org